supported by the National Natural Science Foundation of China(81872785);Shanghai Municipal Commission of Science and Technology of China(21S11904500);Major Scientific and Technological Special Project of Zhongshan City(191022172638719 and 210205143867019);CAS Bohai Rim Advanced Research Institute for Drug Discovery Project(LX211005);the Research&Development Plan in Key Areas of Guangdong Province(2022B1111070007).
Clinical application of PD-1 and PD-L1 monoclonal antibodies (mAbs) is hindered by their relatively low response rates and the occurrence of drug resistance. Co-expression of B7-H3 with PD-L1 has been found in various...
Variable Heavy-chain Homodimer (VHH) or Nanobody is a recombinant dromedary antibody fragment which is classified as the smallest antibody fragments with the highest binding affinity and specificity of the original wh...